Pleiotropic effects of statins and early benefit in the PROVE IT-TIMI-22 study.
Poli
Andrea
A
Pujia
Arturo
A
D000069059:Atorvastatin; D002097:C-Reactive Protein; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D023381:Endpoint Determination; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy*; D017035:Pravastatin / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D015203:Reproducibility of Results
D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D002097:C-Reactive Protein; D000069059:Atorvastatin; D017035:Pravastatin